Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Test Conducted, Demand & Sales Analysis by Product & End-User The global DNA sequencing market will witness a robust CAGR of 17.12%, valued at $10.5 billion in 2021, expected to appreciate and reach $44 billion by 2030, confirms Strategic Market Research. In 2019, North America had the highest DNA sequencing market size, with 44.3% of its total revenue share. DNA sequencing is a laboratory method to determine the sequences of bases {adenine (A), cytosine (C), guanine (G) and thymine (T)} in a DNA molecule. A sample containing the DNA to be sequenced is prepared. The target sequence is then amplified using polymerase chain reaction (PCR). The amplicons obtained are then purified thoroughly, followed by preparations for the sequencing of the DNA. The DNA is then sequenced to obtain the required data, which is then analyzed thoroughly. It has been declared by the National Human Genome Research Institute (NHGRI) that all human beings are 99.9% identical in their genetic makeup. The remaining 0.1% is studied using DNA sequencing to determine the causes of the diseases. This technique has extensive applications in molecular biology, evolutionary biology, metagenomics, virology, medicine, and forensic investigations. Market Drivers - Technological Advancements in DNA sequencing, Increasing Application in Clinical Diagnosis and Drug Discovery Technological improvements in DNA sequencing have helped immensely to drive the market growth. According to the NHGRI, since the completion of the Human Genome Project, technological advancements and improvements have gained speed and lowered costs to a point where some labs can sequence over 100 trillion bases per year. DNA sequencing equipment like the Biomek 4000, Hudson Robotics SOLO, Formulatrix Mantis, Hamilton Microlab NIMBUS, Hamilton Genomic STARlet, Eppendorf epMotion 5075t, Beckman Coulter Biomek i5, Tecan NGS, PerkinElmer Sciclone G3 NGS and NGSx Workstation, Hamilton NGS STAR, Beckman Coulter Biomek i7, and the Agilent Bravo NGS have ameliorated the process involved in DNA sequencing. DNA sequencing technology held more significant potential in clinical research. According to the NIH, about 7000 rare diseases affect 25 to 30 million Americans. Rare diseases are mostly caused by genetic disorders. Thus, genomic sequencing-based diagnosis can be used in rare-disease management, positively impacting the market growth. Market Restraints - High Costs, Lack of Professional Expertise and Data Privacy The machines used in different stages of DNA sequencing are found to be expensive. The National Human Genome Research Institute estimated that the total cost of the procedure amounts to around USD 300 million. This could hinder DNA sequencing, causing a roadblock in its market growth. Professional expertise in DNA sequencing is not available everywhere. Thus, niche methods and products in DNA sequencing take a longer time to be discovered, thus impeding the market growth. Genetic data privacy is a significant concern for patients, hindering the market growth. According to a study by the NCBI, only 10% of biopharmaceutical companies completely anonymized their data. The non-anonymization of data by such companies could lead to data theft and exploitation by different companies, which could impede the market growth. Market Opportunities - Adoption of Newer Procedures The increased usage of newer procedures in DNA sequencing can eventually boost the market growth. Methods like high-throughput sequencing, ion-torrent sequencing, pyrosequencing, single-molecule real-time sequencing, sequencing by synthesis, sequencing by ligation, combinatorial probe anchor synthesis, GenapSys sequencing, Sanger sequencing and Nanopore sequencing that employ electrical tunnelling, hybridisation, mass spectrometry, in vitro virus mRNA display, microscopy and microfluidics that can be used in DNA sequencing, DNA synthesis, RNA sequencing, gene sequencing, and sample preparation for DNA and RNA polymerase are expected to provide ample growth opportunities for the market in future. Further, Newer cDNA sequencing methods are also being discovered. It is also because cDNA sequencing methods are regarded as one of the major opportunity providers for market growth in the future. A cDNA is a DNA strand generated in vitro from cellular mRNA. Market Analysis Of Different Segments Covered in the Report Based on Product Consumables Instruments Services Based on Technology Sanger Sequencing Next-Generation Sequencing (NGS) Whole Genome Sequencing (WGS) Whole Exome Sequencing (WES) Targeted Sequencing and Resequencing Third Generation DNA Sequencing Single-Molecule Real-Time Sequencing (SMRT) Nanopore Sequencing Based on Workflow Pre-sequencing Sequencing Data Analysis Based on Application Oncology Reproductive health Clinical Investigation Agri genomics and Forensics HLA Typing/Immune System Monitoring Metagenomics, Epidemiology and Drug Development Consumer Genomics Others Based on End-Use Academic Research Clinical Research Hospitals and Clinics Pharmaceutical and Biotechnology Companies Other Users Regional Coverage Analysis North America United States of America Canada Mexico Rest of North America Europe Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific China Japan India Rest of APAC LAMEA Brazil Argentina UAE Rest of LAMEA Segments Analysis & Insights Based on product, Consumables held the largest DNA sequencing market share of 43% in 2019. The wide availability of reagents and kits to cater to library construction, such as DNA fragmentation, enrichment, adapter ligation, amplification, and quality control, contributed to the maximum share in this segment. Based on technology, the Next-Generation Sequencing (NGS) segment held the largest market share of 58.6% in 2019. Next-Generation Sequencing is the method of high-throughput DNA sequencing to determine the complete genome sequence of an organism. The advances in technology and the reducing cost of sequencing have made genome sequencing faster, more affordable, and more accurate. According to a study published in the NCBI, NGS usually took less than a day to complete. In contrast, Sanger sequencing took over a decade. According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021. According to the American Journal of Clinical Pathology, 98.7% of DNA sequencing cases using NGS were successful. The whole-genome sequencing market size is expected to grow significantly from 2020 to 2030. Whole-genome sequencing was instrumental in determining the virus behind COVID-19. Based on workflow, the Sequencing segment held the maximum revenue share of 52.9% in 2019. Sequencing enables the sequence profiling of the genome and DNA-protein interactions. Based on application, the Oncology segment comprehensively dominated the market for DNA sequencing with a share of 24.4% in 2019. This technology has the maximum potential for developing cancer diagnostics and therapeutics. According to the National Centre for Health Statistics, around 2 million new cancer cases and 600,000 cancer-related deaths are expected by 2022. The increasing number of cancer cases proliferates the demand for new cancer diagnostics and therapeutics, which drives the segment’s growth. The metagenomics, epidemiology and DNA sequencing in the drug discovery market segment is expected to grow at a CAGR of around 17.5 per cent from 2020 to 2030. According to the American Society for Clinical Pharmaceuticals and Therapeutics, the success rate of a drug, from inception to market approval, is only 10-20%. DNA sequencing can be used to improve the success rate, which would boost this segment’s market growth further. Based on end-use, the academic research segment dominated the market with a revenue share of 55.4% in 2019 due to the increased acceptance and usage of Sanger technology and NGS in academic and institutional research projects. Based on Region, North America has dominated significantly with a market revenue share of 44.3% in 2019. High investment in R&D, continuous technological developments by key players, and availability of technologically advanced healthcare infrastructure have resulted in North America’s more significant revenue share in the market. Asia-Pacific is expected to have substantial growth in this market. The Chinese DNA sequencing market is expected to grow at a CAGR of 19% from 2017 to 2022. DNA Sequencing Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 10.5 billion Revenue forecast in 2030 USD 44 billion Growth rate CAGR of 17.12% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By product, By technology, By workflow, by application, By end-use and By region. By Product Consumables, Instruments, Services By Technology Sanger Sequencing, Next-Generation Sequencing (NGS), Third Generation DNA Sequencing By Workflow Pre-sequencing, Sequencing, Data Analysis By Application Oncology, Reproductive health, Clinical Investigation, Agri genomics and Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Consumer Genomics, Others By End-Use Academic Research, Clinical Research, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other Users By Region Asia Pacific, North America, Europe, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Merck KGaA, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., Siemens Healthineers AG, Pacific Biosciences, Eppendorf, OpenTrons, Gilson, Neotec, TTP Labtech Ltd., Beckman Coulter, Element Biosciences, Inc. Pricing and purchase options Customized buying options are available to meet your exact research needs. Global DNA Sequencing Market Competitive Landscape Analysis The market is very competitive and has a few significant players. These companies make substantial efforts to address consumer demand. They make substantial investments in production, distribution, and total quality management for their portfolio expansion. The key players in this market are: Merck KGaA Thermo Fischer Scientific, Inc. Agilent Technologies, Inc. Illumina, Inc. F. Hoffman-La Roche Ltd. Siemens Healthineers AG Pacific Biosciences Eppendorf OpenTrons Gilson Neotec TTP Labtech Ltd. Beckman Coulter Element Biosciences, Inc. Recent Developments In March 2022, Element Biosciences, Inc. announced the commercial launch of its Element AVIT system. Element believes that through this product launch, the company is delivering on its vision to expand access to high-quality, low-cost, and easy to use genomics tools. In March 2022, Illumina announced its partnership with Trivitron to develop next-generation sequencing (NGS) based in-vitro diagnostic (IVD) tests In India. Illumina believes that the company can make genomic technology and precision medicine available for all through this partnership. In January 2021, SPT Labtech announced its collaboration with Thermo Fisher Scientific to jointly market solutions that could enable variant detection at a fraction of the cost. SPT Labtech and Thermo Fisher believe that by automating and miniaturising NGS processes, scientists can expand their research’s scope and ultimately generate insights into human health. In May 2020, F. Hoffman-La Roche Ltd. announced the acquisition of Stratos Genomics to advance the development of Roche’s nanopore sequencer. Roche believes that the acquisition can help address clinical research demands, which could help resolve patient needs. In January 2020, Agilent Technologies, Inc. announced the launch of its Agilent SureSelect XT HS2 DNA kit to address key challenges laboratories might encounter while preparing DNA sequencing libraries. Agilent Technologies believes that the kit will help laboratory scientists accelerate their capture-based enrichment library preparation without sacrificing quality. Various Leading DNA Sequencing Devices that Key Market Leaders Develop Name of the Product Function Company OpenTrons OT-2 Pipetting for genomics, proteomics, cell-based assays and drug discovery OpenTrons Gilson Pipetmax Pipetting for biological assays Gilson Neotec EzMate Pipetting for PCR/ qPCR sample preparation Neotec TTP Labtech Mosquito HV Genomics Pipetting for miniaturised molecular biology TTP Labtech Ltd. Beckman Coulter Labcyte Echo 525 Biochemical and Genomics Reagent Transfer Beckman Coulter Frequently Asked Question About This Report What are the key drivers to the growth of the market? The major factors that contribute to the growth of the market are technological advancements in DNA sequencing and increasing applications in clinical diagnosis and drug discovery. Which segment holds the maximum share in the market based on technology? The Next-Generation Sequencing segment held the highest share in the market based on technology, with a revenue share of 58.6% in 2019. Which segment holds the highest share in the market based on application? The oncology segment held the maximum revenue share in the market, with a share of 24.4% in 2019. Which segment holds the most significant revenue share in the market based on region? The North American region held the most significant revenue share in the market, with a revenue contribution of 44.3% in 2019. What are the DNA sequencing market growth? The global DNA sequencing market is expected to grow at a compound annual growth rate (CAGR) of 17.12 % from 2021 to 2030 to reach USD 44 Billion by 2030. How big is the DNA sequencing market? The global DNA sequencing market size was $ 10.5 Bn in 2021 and is predicted to reach $ 44 Bn by 2030, with a CAGR of 17.12 %. Sources https://www.genome.gov/17516714/2006-release-about-whole-genome-association-studies https://rarediseases.org/wp-content/uploads/2019/01/RDD-FAQ-2019.pdf https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12980 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/ https://sapac.illumina.com/science/technology/next-generation-sequencing/beginners/ngs-cost.html c1. Introduction 1.1. Study Objective 1.2. market Definition 1.3. Study Scope 1.3.1. markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing market Size by Top-Down Analysis 2.5. market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 DNA Sequencing market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 market Summary 4. Industry Outlook 4.1 market Snapshot 4.2 Global DNA Sequencing market 4.2.1 Global DNA Sequencing market, 2021 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global DNA Sequencing market, By Product, 2021 - 2030 (USD Million) 4.5 By Technology Business Analysis 4.5.1 Global DNA Sequencing market, By Technology, 2021 - 2030 (USD Million) 4.6 By Workflow Business Analysis 4.6.1 Global DNA Sequencing market, By Workflow, 2021 - 2030 (USD Million) 4.7 By End-User Business Analysis 4.7.1 Global DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 4.8 ApplicationBusiness Analysis 4.8.1 Global DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 4.9 Value Chain Analysis 4.10 market Variable Analysis 4.10.1 market Drivers Analysis 4.10.2 market Restraints Analysis 4.11 Business Environment Analysis Tool 4.11.1 DNA Sequencing market PEST analysis 4.11.2 DNA Sequencing market Porter’s analysis 4.12 Penetration & Growth Prospect Mapping 5. market Dynamics 5.1. Introduction 5.2. market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On DNA Sequencing market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2021) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company market Share Analysis 6.2. Manufacturers DNA Sequencing Manufacturing Sites, Area Served, Product Type 6.3. DNA Sequencing market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global DNA Sequencing market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Consumables 7.3.1. Consumables market, 2021 - 2030 (USD Million) 7.4. Instruments 7.4.1. Instruments market, 2021 - 2030 (USD Million) 7.5. Services 7.5.1 Services market, 2021 - 2030 (USD Million) 8. Global DNA Sequencing market: By Technology Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Sanger Sequencing 8.3.1. Sanger Sequencing market, 2021 - 2030 (USD Million) 8.4. Next-Generation Sequencing (NGS) 8.4.1. Next-Generation Sequencing (NGS) market, 2021 - 2030 (USD Million) 8.4.1.1 Whole Genome Sequencing (WGS) market, 2021 - 2030 (USD Million) 8.4.1.2 Whole Exome Sequencing (WES) market, 2021 - 2030 (USD Million) 8.4.1.3 Targeted Sequencing and Resequencing 8.5 Third Generation DNA Sequencing 8.5.1 Third Generation DNA Sequencing market, 2021 - 2030 (USD Million) 8.5.1 Single-Molecule Real-Time Sequencing (SMRT) market, 2021 - 2030 (USD Million) 8.5.1 Nanopore Sequencing market, 2021 - 2030 (USD Million) 9. Global DNA Sequencing market: By Workflow Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Pre-sequencing 9.3.1. Pre-sequencing market, 2021 - 2030 (USD Million) 9.4. Sequencing 9.4.1. Sequencing market, 2021 - 2030 (USD Million) 9.5 Data Analysis 9.5.1 Data Analysis market, 2021 - 2030 (USD Million) 10. Global DNA Sequencing market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Academic Research 10.3.1. Academic Research market, 2021 - 2030 (USD Million) 10.4. Clinical Research 10.4.1. Clinical Research market, 2021 - 2030 (USD Million) 10.5 Hospitals and Clinics 10.5.1 Hospitals and Clinics market, 2021 - 2030 (USD Million) 10.6 Pharmaceutical and Biotechnology Companies 10.6.1 Pharmaceutical and Biotechnology Companies market, 2021 - 2030 (USD Million) 10.7 Others Users 10.7.1 Others Users market, 2021 - 2030 (USD Million) 11. Global DNA Sequencing market: By Application Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2021-2030) 11.3. Oncology 11.3.1. Oncology market, 2021 - 2030 (USD Million) 11.4.Reproductive health 11.4.1. Reproductive health market, 2021 - 2030 (USD Million) 11.5 Clinical Investigation 11.5.1 Clinical Investigation market, 2021 - 2030 (USD Million) 11.6 Agri genomics and Forensics 11.6.1 Agri genomics and Forensics market, 2021 - 2030 (USD Million) 11.7 HLA Typing/Immune System Monitoring 11.7.1 HLA Typing/Immune System Monitoring market, 2021 - 2030 (USD Million) 11.8 Metagenomics, Epidemiology and Drug Development 11.8.1 Metagenomics, Epidemiology and Drug Development market, 2021 - 2030 (USD Million) 11.9 Consumer Genomics 11.9.1 Consumer Genomics market, 2021 - 2030 (USD Million) 12. Global DNA Sequencing market: Region 12.1 North America 12.1.1. North America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4. North America DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.1.5. North America DNA Sequencing market, by Country, 2021 - 2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4.2.2. Canada DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.1.4.2.3. Canada DNA Sequencing market, by Applications, 2021 - 2030 (USD Million) 12.2. Europe 12.2.1. Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.2. Europe DNA Sequencing market, by By Application, 2021 - 2030 (USD Million) 12.2.5. Europe DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.1.2. U.K. DNA Sequencing market, By Applications, 2021 - 2030 (USD Million) 12.2.4.1.3. U.K. DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.2.2. Germany DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.2.4.2.3. Germany DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.3.2. France DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.2.4.3.3. France DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.4.2. Rest of Europe DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.2.4.4.3. Rest of Europe DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.2. Asia Pacific DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.3.5. Asia Pacific DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.1.2. China DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.3.4.1.3. China DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.2.2. India DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.3.4.2.3. India DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. JapanDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.3.3. Japan DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.4.3. South Korea DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFICDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFICDNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4. Latin America 12.4.1. Latin America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.3. Latin America DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4. Latin America DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.1.3. Brazil DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.2.3. Mexico DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin AmericaDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.3.3. Rest of the Latin AmericaDNA Sequencing market, by Application, 2021 - 2030 (USD Million) 13. Competitive Landscape 13.1 Merck KGaA 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. Thermo Fischer Scientific, Inc. 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. Agilent Technologies, Inc. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. Illumina, Inc. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. F. Hoffman-La Roche Ltd. 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Siemens AG. 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. Pacific Biosciences. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Eppendorf. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development List of Tables (52 Tables) TABLE 1. DNA Sequencing market, By Product, 2021-2030 (USD Million) TABLE 2. DNA Sequencing market FOR Consumables, BY REGION, 2021-2030 (USD Million) TABLE 3. DNA Sequencing market FOR Instruments, BY REGION, 2021-2030 (USD Million) TABLE 4. DNA Sequencing market FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 5. DNA Sequencing market FOR Software, BY REGION, 2021-2030 (USD Million) TABLE 6. DNA Sequencing market, By Technology, 2021-2030 (USD Million) TABLE 7. DNA Sequencing market FOR Sanger Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 8. DNA Sequencing market FOR Next-Generation Sequencing (NGS), BY REGION, 2021-2030 (USD Million) TABLE 9. DNA Sequencing market FOR Third Generation DNA Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 10. DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 11. DNA Sequencing market, By Workflow, 2021-2030 (USD Million) TABLE 12. DNA Sequencing market FOR Pre-sequencing, BY REGION, 2021-2030 (USD Million) TABLE 13. DNA Sequencing market FOR Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 14. DNA Sequencing market FOR Data Analysis, BY REGION, 2021-2030 (USD Million) TABLE 15. DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 16. DNA Sequencing market FOR Academic Research, BY REGION, 2021-2030 (USD Million) TABLE 17. DNA Sequencing market FOR Clinical Research, BY REGION, 2021-2030 (USD Million) TABLE 18. DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 19. DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 20. DNA Sequencing market FOR Oncology, BY REGION, 2021-2030 (USD Million) TABLE 21. DNA Sequencing market FOR Reproductive health, BY REGION, 2021-2030 (USD Million) TABLE 22. DNA Sequencing market FOR Clinical Investigation, BY REGION, 2021-2030 (USD Million) TABLE 23. DNA Sequencing market, BY REGION, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA DNA Sequencing market, BY Applications, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 28. EUROPE DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. EUROPE DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 30. EUROPE DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 34. LAMEA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 36. LAMEA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 37. Merck KGaA: COMPANY SNAPSHOT TABLE 38. Merck KGaA: OPERATING SEGMENTS TABLE 39. Thermo Fischer Scientific, Inc: COMPANY SNAPSHOT TABLE 40. Thermo Fischer Scientific, Inc: OPERATING SEGMENTS TABLE 41. Agilent Technologies, Inc: COMPANY SNAPSHOT TABLE 42. Agilent Technologies, Inc: OPERATING SEGMENTS TABLE 43. Illumina, Inc: COMPANY SNAPSHOT TABLE 44. Illumina, Inc: OPERATING SEGMENTS TABLE 45. F. Hoffman-La Roche Ltd: COMPANY SNAPSHOT TABLE 46. F. Hoffman-La Roche Ltd: OPERATING SEGMENTS TABLE 47. Siemens AG: COMPANY SNAPSHOT TABLE 48. Siemens AG: OPERATING SEGMENTS TABLE 49. Pacific Biosciences: COMPANY SNAPSHOT TABLE 50. Pacific Biosciences: OPERATING SEGMENTS TABLE 51. Eppendorf: COMPANY SNAPSHOT TABLE 52. Eppendorf: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 DNA Sequencing market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: DNA Sequencing market Figure 4 Research Methodology: Hypothesis Building Figure 5 DNA Sequencing market: Application-Based Estimation Figure 6 Top 8 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 DNA Sequencing market, By Product, 2019 vs. 2025 (USD Million) Figure 12 DNA Sequencing market, By Technology, 2019 vs. 2025 (USD Million) Figure 13 DNA Sequencing market, By Workflow, 2019 vs. 2025 (USD Million) Figure 14 DNA Sequencing market, By End-User, 2019 vs. 2025 (USD Million) Figure 15 DNA Sequencing market Share, By Application Type, 2019 vs. 2025 Figure 16 Geographical Snapshot of the DNA Sequencing market Figure 17 Consumables to Witness Higher CAGR in DNA Sequencing market for Product Segment during Forecast Period. Figure 18 Next-Generation DNA Sequencing to Witness Higher CAGR in DNA Sequencing market for Technology Segment during Forecast Period. Figure 19 Sequencing segment to Witness Higher CAGR in DNA Sequencing market for Workflow Segment during Forecast Period. Figure 20 Academic research to Witness Higher CAGR in DNA Sequencing market for End-User Segment during Forecast Period. Figure 21 Oncology segment to Witness Higher CAGR in DNA Sequencing market for Application Segment during Forecast Period. Figure 22 North America Accounted for the Largest Share of the DNA Sequencing market, By Regional Basis, in 2019 Figure 23 DNA Sequencing market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: DNA Sequencing market Snapshot Figure 25 Asia Pacific: DNA Sequencing market Snapshot Figure 26 Vendor Dive: Evaluation Overview